STACi vs MACI for knee cartilage repairSTACi performs knee cartilage repair in one operation by combining bone-marrow stem cells with patient chondrocytes on a three-dimensional scaffold — differing from MACI in cell composition and scaffold structure, though lacking randomised-trial evidence for long-term durability.STACi performs knee cartilage repair in one operation by combining bone-marrow stem cells with patient chondrocytes on a three-dimensional scaffold — differing from MACI in cell composition and scaffold structure, though lacking randomised-trial evidence for long-term durability.
ChondroFiller injection for ankle cartilage defectsChondroFiller is an injectable collagen scaffold that gels in place within a cartilage lesion and recruits the body's own cells to regenerate tissue; it suits focal ankle defects above 150 mm² and avoids surgery, though recovery requires 12 weeks of protected weight-bearing.ChondroFiller is an injectable collagen scaffold that gels in place within a cartilage lesion and recruits the body's own cells to regenerate tissue; it suits focal ankle defects above 150 mm² and avoids surgery, though recovery requires 12 weeks of protected weight-bearing.
What the ChondroFiller evidence actually showsChondroFiller, a collagen scaffold, increases knee function scores by 30 points at three years — roughly double the clinical significance threshold — but no large independent randomised trial has been completed.ChondroFiller, a collagen scaffold, increases knee function scores by 30 points at three years — roughly double the clinical significance threshold — but no large independent randomised trial has been completed.
ChondroFiller injection cost and UK accessChondroFiller injection costs £2,100–£8,000 in the UK, is delivered as a single ultrasound-guided outpatient procedure, and is not commissioned by the NHS.ChondroFiller injection costs £2,100–£8,000 in the UK, is delivered as a single ultrasound-guided outpatient procedure, and is not commissioned by the NHS.
Questions to ask before a ChondroFiller injectionChondroFiller is an injectable collagen scaffold that prompts the body's cells to rebuild cartilage as it degrades—unlike hyaluronic acid, which lubricates, or permanent fillers, which cushion. Delivered as an outpatient ultrasound-guided procedure, published data show 30-point IKDC improvement at 12 months, though long-term durability beyond two years remains unestablished.ChondroFiller is an injectable collagen scaffold that prompts the body's cells to rebuild cartilage as it degrades—unlike hyaluronic acid, which lubricates, or permanent fillers, which cushion. Delivered as an outpatient ultrasound-guided procedure, published data show 30-point IKDC improvement at 12 months, though long-term durability beyond two years remains unestablished.
ChondroFiller Injection for Shoulder Cartilage DefectsChondroFiller is an ultrasound-guided collagen scaffold that recruits the patient's own progenitor cells to repair focal shoulder cartilage defects; early observational data reports marked pain reduction and functional improvement from the outpatient procedure.ChondroFiller is an ultrasound-guided collagen scaffold that recruits the patient's own progenitor cells to repair focal shoulder cartilage defects; early observational data reports marked pain reduction and functional improvement from the outpatient procedure.
ChondroFiller injection for hip cartilage defectsChondroFiller is an injectable collagen scaffold placed into the hip via ultrasound guidance that recruits the patient's own progenitor cells to differentiate into repair cartilage; the procedure is completed in an outpatient clinic without surgical debridement or general anaesthesia.ChondroFiller is an injectable collagen scaffold placed into the hip via ultrasound guidance that recruits the patient's own progenitor cells to differentiate into repair cartilage; the procedure is completed in an outpatient clinic without surgical debridement or general anaesthesia.
ChondroFiller injection recovery timelineChondroFiller is an outpatient collagen scaffold injection that recruits the patient's own stem cells to repair cartilage; most people notice improvement within 6–12 weeks, though complete tissue replacement takes one to two years.ChondroFiller is an outpatient collagen scaffold injection that recruits the patient's own stem cells to repair cartilage; most people notice improvement within 6–12 weeks, though complete tissue replacement takes one to two years.
ChondroFiller injection for ankle osteochondral lesionsChondroFiller is an injectable collagen scaffold that repairs ankle cartilage by recruiting the patient's own cells to rebuild the lesion, rather than introducing foreign cells or merely masking symptoms.ChondroFiller is an injectable collagen scaffold that repairs ankle cartilage by recruiting the patient's own cells to rebuild the lesion, rather than introducing foreign cells or merely masking symptoms.
ChondroFiller safety across 19,000 real-world treatmentsAcross 19,000 real-world treatments, ChondroFiller records no serious adverse device effects and a reoperation rate of 3–8%, compared to 41% for microfracture and 37% for ACI/MACI.Across 19,000 real-world treatments, ChondroFiller records no serious adverse device effects and a reoperation rate of 3–8%, compared to 41% for microfracture and 37% for ACI/MACI.
Who qualifies for ChondroFiller injectionChondroFiller recruits the patient's own cells into a collagen scaffold placed within focal cartilage defects; candidacy requires mechanical joint stability and absence of widespread degeneration.ChondroFiller recruits the patient's own cells into a collagen scaffold placed within focal cartilage defects; candidacy requires mechanical joint stability and absence of widespread degeneration.
ChondroFiller injection vs knee replacementChondroFiller is a collagen scaffold injection that recruits the patient's own repair cells to treat focal cartilage defects. Knee replacement suits end-stage, widespread wear; the choice between them depends on imaging findings, not age.ChondroFiller is a collagen scaffold injection that recruits the patient's own repair cells to treat focal cartilage defects. Knee replacement suits end-stage, widespread wear; the choice between them depends on imaging findings, not age.